A Marginal Call in Breast Cancer

By Mr Daniel Leff, Reader in Breast Surgery, Department of Surgery & Cancer, Faculty of Medicine  As we move towards the end of Breast Cancer Awareness month, it is important to celebrate the many success of breast cancer research and treatment  – whilst breast cancer may be common, more women than ever before are surviving thanks to earlier diagnosis and an improved understanding of the biology of breast cancer leading to more personalised medicine. That said, we still face major challenges. The one that is on the forefront of my mind is the “margins problem” once called the ‘hidden epidemic of breast cancer’.

Pharmacists – the new guardians of breast cancer care?

By guest blogger Chanice Henry, Editor, Pharma IQ

In the fight against one of the world’s most widespread diseases, new research has found that pharmacists are key in the optimisation of medical treatment for breast cancer patients.

Breast cancer is the most common cancer that occurs in women. In 2012 there were 1.7 million new diagnoses ­– which equated to 12% of all new cancer cases. Less than one per cent of breast cancer develops in males.

Despite its prevalence, death rates from this form of cancer have been consistently declining over the past 25 years due to better awareness and advancing treatment options.